The Scopio Labs’ Story

We founded Scopio Labs to find a better way to perform laboratory diagnosis for malignancies and other illnesses. And we quickly realized that one of the biggest obstacles in the diagnostic process was inaccessibility to high-quality digitized microscopic data.
Remarkably, much of the medical world still relies on diagnostics performed using the manual microscope, which is analog, outdated and labor-intensive. With manual microscopy, there is no easy way to share microscopic data, collaborate with specialists, or perform the sort of AI-based image analysis that is becoming commonplace in other industries.

How to digitize microscopy and bring it into the modern age? This was the challenge. But given our backgrounds in applied physics and managing high-tech startups, a challenge we hoped was surmountable. And so our work began.

Soon we had the realization that the key to success would be figuring out how to capture high-resolution images of whole slides, without using prohibitively expensive hardware.

This is where the Scopio Labs story takes off.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 816551